Sedation in the intensive care unit

Minerva Anestesiologica

Volumn 78, Issue 3, 2012, Pages 369-380

  McGrane, S ^a   Pandharipande, P P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; Clinical protocols; Hypnotic and sedatives

Indexed keywords

BENZODIAZEPINE; CLONIDINE; DEXMEDETOMIDINE; FENTANYL; HYDROMORPHONE; INHALATION ANESTHETIC AGENT; KETAMINE; LORAZEPAM; MIDAZOLAM; MORPHINE; PROPOFOL; REMIFENTANIL; SEDATIVE AGENT; SUFENTANIL;

ADJUVANT THERAPY; AGITATION; ALCOHOL WITHDRAWAL; ANALGESIA; ANALGESIC ACTIVITY; ANALGOSEDATION; AROUSAL; ARTIFICIAL VENTILATION; BISPECTRAL INDEX; BRADYCARDIA; BREATHING; BURN; CLINICAL PROTOCOL; CONSCIOUSNESS LEVEL; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DELIRIUM TREMENS; DISEASE CONTROL; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; EPILEPTIC STATE; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; PAIN; PRESCRIPTION; PROPOFOL INFUSION SYNDROME; RESPIRATION DEPRESSION; REVIEW; SEDATION; SURVIVAL TIME; TRANQUILIZING ACTIVITY;

ANALGESICS; CONSCIOUS SEDATION; CONSCIOUSNESS MONITORS; CRITICAL ILLNESS; DEEP SEDATION; DELIRIUM; DRUG MONITORING; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; INTENSIVE CARE UNITS; LENGTH OF STAY; MULTICENTER STUDIES AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PSYCHOMOTOR AGITATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX;

EID: 84857519632     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Salgado DR, Favory R, Goulart M, Brimioulle S, Vincent JL. Toward less sedation in the intensive care unit: A prospective observational study. J Crit Care 2011;26:113-121.
2. Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007;106:687-695.
3. Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD. Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 2009;37:3031-3039.
4. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-141.
5. Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008;371:126-134.
6. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998;114:541-548.
7. Pandharipande P, Shintani A, Peterson J, Girard TD, Thompson JL, Shintani AK et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104:21-26.
8. Nelson JE, Meier DE, Litke A, Natale DA, Siegel RE, Morrison RS. The symptom burden of chronic critical illness. Crit Care Med 2004;32:1527-1534.
9. Gehlbach BK, Kress JP. Sedation in the intensive care unit. Curr Opin Crit Care 2002;8:290-298.
10. Epstein J, Breslow MJ. The stress response of critical illness. Crit Care Clin 1999;15:17-33.
11. Martin J, Heymann A, Basell K, Baron R, Biniek R, Bürkle H et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version. Ger Med Sci 2010;8: Doc02.
12. Agarwal V, O'Neill PJ, Cotton BA, Pun BT, Haney S, Thompson J et al. Prevalence and risk factors for development of delirium in burn intensive care unit patients. J Burn Care Res 2010;31:706-715.
13. Pandharipande P, Cotton BA, Shintani A, Thompson J, Pun BT, Morris JA Jr et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008;65:34-41.
14. Rozendaal FW, Spronk PE, Snellen FF, Schoen A, van Zanten AR, Foudraine NA et al. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2009;35:291-8.
15. Breen D, Karabinis A, Malbrain M, Morais R, Albrecht S, Jarnvig IL et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomized trial [ISRCTN47583497]. Crit Care 2005;9:R200-R10.
16. Strom T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010;375:475-480.
17. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974;2:656-659.
18. Pandharipande P, Cotton BA, Shintani A, Thompson J, Pun BT, Morris JA Jr et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008;65:34-41.
19. Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 2001;27:1297-1304.
20. Marcantonio ER, Juarez G, Goldman L, Mangione CM, Ludwig LE, Lind L et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994;272:1518-1522.
21. Dahaba AA, Grabner T, Rehak PH, List WF, Metzler H. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology 2004;101:640-646.
22. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999;27:1325-1329.
23. Muellejans B, Lopez A, Cross MH, Bonome C, Morrison L, Kirkham AJ. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713]. Crit Care 2004;8:R1-R11.
24. Fraser GL, Prato BS, Riker RR, Berthiaume D, Wilkins ML. Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU. Pharmacotherapy 2000;20:75-82.
25. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363:1107-1116.
26. Hughes CG, Pandharipande PP. Review articles: the effects of perioperative and intensive care unit sedation on brain organ dysfunction. Anesth Analg 2011;112:1212-1217.
27. Zapantis A, Leung S. Tolerance and withdrawal issues with sedation. Crit Care Nurs Clin North Am 2005;17:211-223.
28. Galley HF, Dubbels AM, Webster NR. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 1998;86:1289-1293.
29. Nseir S, Makris D, Mathieu D, Durocher A, Marquette CH. Intensive Care Unit-acquired infection as a side effect of sedation. Crit Care 2010;14:R30.
30. Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001;27:1892-1900.
31. Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009;180:1092-1097.
32. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291:1753-1762.
33. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298:2644-2653.
34. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301:489-499.
35. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999;27:2609-2615.
36. Botha JA, Mudholkar P. The effect of a sedation scale on ventilation hours, sedative, analgesic and inotropic use in an intensive care unit. Crit Care Resusc 2004;6:253-257.
37. Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003;289:2983-2991.
38. Patel RP, Gambrell M, Speroff T, Scott TA, Pun BT, Okahashi J et al. Delirium and sedation in the intensive careunit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 2009;37:825-832.
39. Consales G, Chelazzi C, Rinaldi S, De Gaudio AR. Bispectral Index compared to Ramsay score for sedation monitoring in intensive care units. Minerva Anestesiol 2006;72:329-336.
40. Yamashita K, Terao Y, Inadomi C, Takada M, Fukusaki M, Sumikawa K. Age-dependent relationship between bispectral index and sedation level. J Clin Anesth 2008;20:492-495.
41. Ryder-Lewis MC, Nelson KM. Reliability of the Sedation- Agitation Scale between nurses and doctors. Intensive Crit Care Nurs 2008;24:211-217.
42. Riker RR, Fraser GL, Simmons LE, Wilkins ML. Validating the Sedation-Agitation Scale with the Bispectral Index and Visual Analog Scale in adult ICU patients after cardiac surgery. Intensive Care Med 2001;27:853-858.
43. Sennholz G. Bispectral analysis technology and equipment. Minerva Anestesiol 2000;66:386-388.
44. Liu J, Singh H, White PF. Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology 1996;84:64-69.
45. Doi M, Gajraj RJ, Mantzaridis H, Kenny GN. Relationship between calculated blood concentration of propofol and electrophysiological variables during emergence from anaesthesia: comparison of bispectral index, spectral edge frequency, median frequency and auditory evoked potential index. Br J Anaesth 1997;78:180-184.
46. Liu J, Singh H, White PF. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth Analg 1997;84:185-189.
47. LeBlanc JM, Dasta JF, Kane-Gill SL. Role of the bispectral index in sedation monitoring in the ICU. Ann Pharmacother 2006;40:490-500.
48. Sessler CN, Pedram S. Protocolized and target-based sedation and analgesia in the ICU. Crit Care Clin 2009;25:489-513, 8.
49. Quenot JP, Ladoire S, Devoucoux F, Doise JM, Cailliod R, Cunin N et al. Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia. Crit Care Med 2007;35:2031-2036.
50. Robinson BR, Mueller EW, Henson K, Branson RD, Barsoum S, Tsuei BJ. An analgesia-delirium-sedation protocol for critically ill trauma patients reduces ventilator days and hospital length of stay. J Trauma 2008;65:517-526.
51. Jackson JC, Girard TD, Gordon SM, Thompson JL, Shintani AK, Thomason JW et al. Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med 2010;182:183-191.
52. Kress JP, Gehlbach B, Lacy M, Pliskin N, Pohlman AS, Hall JB. The long-term psychological effects of daily sedative interruption on critically ill patients. Am J Respir Crit Care Med 2003;168:1457-1461.
53. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlle d trial. Lancet 2009;373:1874-1882.
54. Mesnil M, Capdevila X, Bringuier S, Trine PO, Falquet Y, Charbit J et al. Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Med 2011;37:933-941.
55. Angelini G, Ketzler JT, Coursin DB. Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit. Crit Care Clin 2001;17:863-880.
56. Beretta L, De VA, Grandi E. Sedation in neurocritical patients: is it useful? Minerva Anestesiol 2011;77:828-834.
57. Mehta S, Burry L, Fischer S, Martinez-Motta JC, Hallett D, Bowman D et al. Canadian survey of the use of seda-tives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006;34:374-380.
58. Rhoney DH, Murry KR. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med 2003;18:139-145.
59. Mehta S, McCullagh I, Burry L. Current sedation practices: lessons learned from international surveys. Crit Care Clin 2009;25:471-478.
60. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007;33:66-73.
61. Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med 2004;32:1272-1276.
62. Woo JH, Au Eong KG, Kumar CM. Conscious sedation during ophthalmic surgery under local anesthesia. Minerva Anestesiol 2009;75:211-219.
63. Barr J. Propofol: a new drug for sedation in the intensive care unit. Int Anesthesiol Clin 1995;33:131-154.
64. Barr J, Egan TD, Sandoval NF, Zomorodi K, Cohane C, Gambus PL et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001;95:324-33.
65. Bentley GN, Gent JP, Goodchild CS. Vascular effects of propofol: smooth muscle relaxation in isolated veins and arteries. J Pharm Pharmacol 1989;41:797-8.
66. Diedrich DA, Brown DR. Analytic reviews: propofol infusion syndrome in the ICU. J Intensive Care Med 2011;26:59-72.
67. Fudickar A, Bein B. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol 2009;75:339-344.
68. Junttila MJ, Gonzalez M, Lizotte E, Benito B, Vernooy K, Sarkozy A et al. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation 2008;117:1890-1893.
69. Carson SS, Kress JP, Rodgers JE, Vinayak A, Campbell-Bright S, Levitt J et al. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 2006;34:1326-1332.
70. Cox CE, Reed SD, Govert JA, Rodgers JE, Campbell-Bright S, Kress JP et al. Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med 2008;36:706-714.
71. Anis AH, Wang XH, Leon H, Hall R. Economic evaluation of propofol for sedation of patients admitted to intensive care units. Anesthesiology 2002;96:196-201.
72. Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 1997;25:33-40.
73. Ho KM, Ng JY. The use of propofol for medium and long-term sedation in critically ill adult patients: a metaanalysis. Intensive Care Med 2008;34:1969-1979.
74. Devlin JW, Roberts RJ. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin 2009;25:431-449, 7
75. Calvey TN, Williams NE. Isomerism and Anaesthetic Drugs. Principles and Practice of Pharmacology for Anaesthetists. 3rd ed. Oxford: Blackwell Science Ltd; 1997. p. 108-145.
76. Greenblatt DJ, Zhao Y, Venkatakrishnan K et al. Mechanism of cytochrome P450-3A inhibition by ketoconazole. J Pharm Pharmacol 2011;63:214-221.
77. Kirby BJ, Collier AC, Kharasch ED, Whittington D, Thummel KE, Unadkat JD. Complex drug interactions of HIV protease inhibitors 1: inactivation, induction, and in-hibition of cytochrome P450 3A by ritonavir or nelfinavir. Drug Metab Dispos 2011;39:1070-1078.
78. Fragen RJ. Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. Clin Ther 1997;19:405-19.
79. Yahwak JA, Riker RR, Fraser GL, Subak-Sharpe S. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy 2008;28:984-991.
80. Maze M, Scarfini C, Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin 2001;17:881-897.
81. Scheinin M, Kallio A, Koulu M, Viikari J, Scheinin H. Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers. Br J Clin Pharmacol 1987;24:443-451.
82. Morandi A, Watson PL, Trabucchi M, Ely EW. Advances in sedation for critically ill patients. Minerva Anestesiol 2009;75:385-391.
83. Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 2010;14:R38.
84. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a metaanalysis. Intensive Care Med 2010;36:926-939.
85. Cox CE, Govert JA. Assessing the comparative value of sedatives in the intensive care unit. Crit Care Med 2010;38:709-711.
86. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992;77:1134-1142.
87. Nielsen H, Mortensen FV, Mulvany MJ. Differential distribution of postjunctional alpha 2 adrenoceptors in human omental small arteries. J Cardiovasc Pharmacol 1990;16:34-40.
88. Baumgartner GR, Rowen RC. Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 1987;147:1223-6.
89. Liatsi D, Tsapas B, Pampori S, Tsagourias M, Pneumatikos I, Matamis D. Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome. Intensive Care Med 2009;35:275-81.
90. Laskowski K, Stirling A, McKay WP, Lim HJ. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth 2011;58:911-923.
91. Hirota K, Lambert DG. Ketamine: new uses for an old drug? Br J Anaesth 2011;107:123-126.
92. Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ 1989;298:1277-80.
93. Sackey PV, Martling CR, Nise G, Radell PJ. Ambient isoflurane pollution and isoflurane consumption during intensive care unit sedation with the Anesthetic Conserving Device. Crit Care Med 2005;33:585-590.
94. Barbara A Coda. Opioids. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical Anesthesia. Fifth ed. Philadelphia, PA: Lippincott Williams and Watkins; 2006. p. 334-383.
95. Kazuhiko Fukuda. Intravenous opioid anesthetics. In: Miller RD, editor. Miller's anesthesia. 6th ed. New York, NY: Elsevier Churchill Livingstone; 2005. p. 380-437.
96. Donnelly AJ, Baughmann VL, Gonzales JP, Tomsik EA. Anesthesiology and Critical Care Drug Handbook. 6th ed. Hudson, Oh: Lexi-Comp; 2005.
97. Stein C, Rosow CE. Analgesics: receptor ligands and opiate narcotics. In: Evers A, Maze M, editors. Anesthetic Pharmacology. First ed. Churchill Livingstone; 2004;457-471.
98. Pharmacokinetic Data. In: Hardman JG, Limbird LE, Goodman Gilman A, editors. The pharmacological basis oftherapeutics. 10th ed. New York, NY: McGraw-Hill; 2001. p. 1924-2023.
99. Hill HF, Coda BA, Tanaka A, Schaffer R. Multiple-dose evaluation of intravenous hydromorphone pharmacokinetics in normal human subjects. Anesth Analg 1991;72: 330-336.
100. Hall LG, Oyen LJ, Murray MJ. Analgesic agents. Pharmacology and application in critical care. Crit Care Clin 2001;17:899-923. 8
101. Roy SD, Flynn GL. Solubility and related physicochemical properties of narcotic analgesics. Pharm Res 1988;5: 580-586.